Legend Biotech (LEGN) Short-term Investments: 2020-2024
Historic Short-term Investments for Legend Biotech (LEGN) over the last 3 years, with Sep 2024 value amounting to -$149.8 million.
- Legend Biotech's Short-term Investments was N/A to -$149.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$149.8 million, marking a year-over-year change of. This contributed to the annual value of $663,000 for FY2023, which is 99.64% down from last year.
- As of Q3 2024, Legend Biotech's Short-term Investments stood at -$149.8 million, which was up 0.50% from -$150.6 million recorded in Q2 2024.
- In the past 5 years, Legend Biotech's Short-term Investments registered a high of $185.6 million during Q4 2022, and its lowest value of -$160.0 million during Q3 2022.
- Its 3-year average for Short-term Investments is -$53.1 million, with a median of -$124.9 million in 2022.
- As far as peak fluctuations go, Legend Biotech's Short-term Investments spiked by 125,200.00% in 2021, and later tumbled by 419.74% in 2022.
- Over the past 5 years, Legend Biotech's Short-term Investments (Quarterly) stood at -$22.7 million in 2020, then skyrocketed by 125,200.00% to $50.0 million in 2021, then tumbled by 419.74% to $185.6 million in 2022, then plummeted by 99.64% to $663,000 in 2023, then reached -$149.8 million in 2024.
- Its Short-term Investments stands at -$149.8 million for Q3 2024, versus -$150.6 million for Q2 2024 and -$150.3 million for Q1 2024.